GeoVax Accelerates GEO-MVA Vaccine Development Amid Global Mpox Crisis
GeoVax Labs, Inc. is expediting the development of its GEO-MVA Mpox vaccine in response to a global surge in cases and the WHO's reaffirmation of Mpox as a public health emergency, highlighting the urgent need for scalable and equitable vaccine solutions.
